ArticleEmerging infectious diseases2026
Use of Salmonella enterica Serovar Typhi Hemolysin E and Lipopolysaccharide IgA to Identify Enteric Fever Cases, South Asia.
Article in Emerging infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
31 authors.
Funding
Abstract
Existing methods to identify patients infected with Salmonella enterica serovar Typhi or Paratyphi are not adequately accurate, affordable, or efficient. We evaluated the performance of antibodies to Salmonella Typhi hemolysin E (HlyE) and lipopolysaccharide (LPS) in Bangladesh, Nepal, and Pakistan for enteric fever case identification. We measured plasma concentrations of HlyE and LPS IgA in blood culture-confirmed enteric fever case-patients and in febrile controls with laboratory-confirmed alternative etiologies. Combining LPS and HlyE IgA discriminated enteric fever cases from other febrile illnesses with an area under the receiver operating characteristic curve (AUC) of 0.93 (specificity 86% at a fixed 90% sensitivity). LPS IgA alone performed nearly as well (AUC 0.92). In children <5 years of age, the combined biomarkers outperformed either biomarker alone (AUC 0.96 vs. 0.94 for HlyE, 0.93 for LPS). Our findings support use of HlyE and LPS IgA-based assays for enteric fever diagnosis in endemic settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.